{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T23:40:42Z","timestamp":1746402042434,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10157-016-1346-9","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T12:43:32Z","timestamp":1477399412000},"page":"895-907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A new peritoneal dialysis fluid for Japanese patients: a randomized non-inferiority clinical trial of safety and efficacy"],"prefix":"10.1007","volume":"21","author":[{"given":"Masaaki","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshindo","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemune","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Maeba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Yorioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Sloand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,25]]},"reference":[{"issue":"1","key":"1346_CR1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.1995.36","volume":"47","author":"J Witowski","year":"1995","unstructured":"Witowski J, Topley N, Jorres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int. 1995;47(1):282\u201393.","journal-title":"Kidney Int"},{"issue":"5","key":"1346_CR2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/ki.1996.204","volume":"49","author":"N Topley","year":"1996","unstructured":"Topley N, Kaur D, Petersen MM, Jorres A, Passlick-Deetjen J, Coles GA, et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int. 1996;49(5):1447\u201356.","journal-title":"Kidney Int"},{"issue":"3","key":"1346_CR3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.1988.195","volume":"34","author":"N Topley","year":"1988","unstructured":"Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int. 1988;34(3):404\u201311.","journal-title":"Kidney Int"},{"issue":"7 Suppl","key":"1346_CR4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1177\/089686089501507S07","volume":"15","author":"FB Pedersen","year":"1995","unstructured":"Pedersen FB. Lactate-versus bicarbonate-based peritoneal dialysis solutions. Perit Dial Int. 1995;15(7 Suppl):S47\u201350 (discussion S1).","journal-title":"Perit Dial Int"},{"issue":"6","key":"1346_CR5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1525-1594.1989.tb01568.x","volume":"13","author":"FJ Manahan","year":"1989","unstructured":"Manahan FJ, Ing BL, Chan JC, Gupta DK, Zhou FQ, Pal I, et al. Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils. Artif Organs. 1989;13(6):495\u20137.","journal-title":"Artif Organs"},{"issue":"3","key":"1346_CR6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000186436","volume":"58","author":"A Jorres","year":"1991","unstructured":"Jorres A, Jorres D, Gahl GM, Kessel M, Muller C, Kottgen E, et al. Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. Nephron. 1991;58(3):276\u201382.","journal-title":"Nephron."},{"issue":"5","key":"1346_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/039139888801100508","volume":"11","author":"BL Ing","year":"1988","unstructured":"Ing BL, Gupta DK, Nawab ZM, Zhou FQ, Rahman MA, Daugirdas JT. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs. 1988;11(5):351\u20134.","journal-title":"Int J Artif Organs"},{"issue":"6","key":"1346_CR8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/0272-6386(95)90057-8","volume":"26","author":"FP Fischer","year":"1995","unstructured":"Fischer FP, Schenk U, Kiefer T, Hubel E, Thomas S, Yatzidis H, et al. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function. Am J Kidney Dis. 1995;26(6):924\u201333.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1346_CR9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/iai.33.1.130-135.1981","volume":"33","author":"AK Duwe","year":"1981","unstructured":"Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun. 1981;33(1):130\u20135.","journal-title":"Infect Immun"},{"issue":"Suppl 3","key":"1346_CR10","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/089686089401403S05","volume":"14","author":"N Topley","year":"1994","unstructured":"Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells. Perit Dial Int. 1994;14(Suppl 3):S21\u20138.","journal-title":"Perit Dial Int"},{"issue":"5","key":"1346_CR11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/089686080002000506","volume":"20","author":"A Tranaeus","year":"2000","unstructured":"Tranaeus A. A long-term study of a bicarbonate\/lactate-based peritoneal dialysis solution\u2014clinical benefits. The Bicarbonate\/Lactate Study Group. Perit Dial Int. 2000;20(5):516\u201323.","journal-title":"Perit Dial Int"},{"issue":"12","key":"1346_CR12","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/ndt\/13.12.3165","volume":"13","author":"GA Coles","year":"1998","unstructured":"Coles GA, O\u2019Donoghue DJ, Pritchard N, Ogg CS, Jani FM, Gokal R, et al. A controlled trial of two bicarbonate-containing dialysis fluids for CAPD\u2014final report. Nephrol Dial Transpl. 1998;13(12):3165\u201371.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"1346_CR13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/089686080102100603","volume":"21","author":"AM Carrasco","year":"2001","unstructured":"Carrasco AM, Rubio MA, Tommero JS, Giron FF, Rico MG, del Peso Gilsanz G, et al. Acidosis correction with a new 25\u00a0mmol\/L bicarbonate\/15\u00a0mmol\/L lactate peritoneal dialysis solution. Perit Dial Int. 2001;21(6):546\u201353.","journal-title":"Perit Dial Int"},{"key":"1346_CR14","unstructured":"Baxter Limited Japan. Clinical Study Report of a Phase III study with BLBC1997. On file with Pharmaceuticals and Medical Devices Agency, Ministry of Health, Labor and Welfare, Tokyo 100-0013, Japan (www.pmda.go.jp)."},{"key":"1346_CR15","unstructured":"Baxter Limited Japan. Clinical Study Report of a Phase III study with BLPD1984. On file with Pharmaceuticals and Medical Devices Agency, Ministry of Health, Labor and Welfare, Tokyo 100-0013, Japan (www.pmda.go.jp)."},{"key":"1346_CR16","unstructured":"Dioos B, Paternot G, Jenvert RM, Duponchelle A, Marshall M, Deenitchina S et al. Biocompatibility of a new bicarbonate containing PD solution, Reguneal\u2014measured as in vitro proliferation of fibroblasts [Abstract]. J Am Soc Nephrol. 2016;27(Abstract Suppl.) (in press)."},{"issue":"Suppl 2","key":"1346_CR17","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1177\/089686089301302S27","volume":"13","author":"A Breborowicz","year":"1993","unstructured":"Breborowicz A. In vitro study on the biocompatibility of the peritoneal dialysis solution. Perit Dial Int. 1993;13(Suppl 2):S105\u20138.","journal-title":"Perit Dial Int"},{"issue":"Suppl 1","key":"1346_CR18","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1681\/ASN.V13suppl_1s97","volume":"13","author":"S Jones","year":"2002","unstructured":"Jones S, Holmes CJ, Mackenzie RK, Stead R, Coles GA, Williams JD, et al. Continuous dialysis with bicarbonate\/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol. 2002;13(Suppl 1):S97\u2013103.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"1346_CR19","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1177\/089686089301302S31","volume":"13","author":"HT Schambye","year":"1993","unstructured":"Schambye HT, Pedersen FB, Christensen HK, Berthelsen H, Wang P. The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate\/lactate ratios. Perit Dial Int. 1993;13(Suppl 2):S116\u20138.","journal-title":"Perit Dial Int"},{"issue":"Suppl 3","key":"1346_CR20","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1177\/089686080102103S17","volume":"21","author":"LA Cooker","year":"2001","unstructured":"Cooker LA, Luneburg P, Holmes CJ, Jones S, Topley N, Bicarbonate\/Lactate Study G. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate\/lactate-based peritoneal dialysis solutions. Perit Dial Int. 2001;21(Suppl 3):S102\u20137.","journal-title":"Perit Dial Int"},{"issue":"4","key":"1346_CR21","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1046\/j.1523-1755.2001.0590041529.x","volume":"59","author":"S Jones","year":"2001","unstructured":"Jones S, Holmes CJ, Krediet RT, Mackenzie R, Faict D, Tranaeus A, et al. Bicarbonate\/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int. 2001;59(4):1529\u201338. doi: 10.1046\/j.1523-1755.2001.0590041529.x .","journal-title":"Kidney Int"},{"issue":"4","key":"1346_CR22","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1046\/j.1523-1755.2003.00883.x","volume":"63","author":"TY Wong","year":"2003","unstructured":"Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int. 2003;63(4):1404\u201316. doi: 10.1046\/j.1523-1755.2003.00883.x .","journal-title":"Kidney Int"},{"issue":"3","key":"1346_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3747\/pdi.2013.00284","volume":"35","author":"TH Yoo","year":"2015","unstructured":"Yoo TH, Lee MJ, Oh HJ, Park JT, Han SH, Kang SW, et al. Is it beneficial to convert to a neutral-pH bicarbonate\/lactate-buffered PD solution in long-term CAPD patients? A Single-Center Prospective Study. Perit Dial Int. 2015;35(3):366\u20139. doi: 10.3747\/pdi.2013.00284 .","journal-title":"Perit Dial Int"},{"issue":"6","key":"1346_CR24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/089686089801800604","volume":"18","author":"GC Cancarini","year":"1998","unstructured":"Cancarini GC, Faict D, De Vos C, Guiberteau R, Tranaeus A, Minetti L, et al. Clinical evaluation of a peritoneal dialysis solution with 33\u00a0mmol\/L bicarbonate. Perit Dial Int. 1998;18(6):576\u201382.","journal-title":"Perit Dial Int"},{"issue":"Suppl 1","key":"1346_CR25","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1177\/089686089601601S24","volume":"16","author":"HT Schambye","year":"1996","unstructured":"Schambye HT. Effect of different buffers on the biocompatibility of CAPD solutions. Perit Dial Int. 1996;16(Suppl 1):S130\u20136.","journal-title":"Perit Dial Int"},{"issue":"4","key":"1346_CR26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ajcn\/44.4.519","volume":"44","author":"RL Veech","year":"1986","unstructured":"Veech RL. The toxic impact of parenteral solutions on the metabolism of cells: a hypothesis for physiological parenteral therapy. Am J Clin Nutr. 1986;44(4):519\u201351.","journal-title":"Am J Clin Nutr."},{"key":"1346_CR27","unstructured":"Baxter Limited Japan. Clinical Study Report of a Phase III study with BLLC1990."},{"key":"1346_CR28","unstructured":"Baxter Limited Japan. Clinical Study Report of a Phase III study with BLPG1999."},{"issue":"1","key":"1346_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000185265","volume":"51","author":"D Sethi","year":"1989","unstructured":"Sethi D, Curtis JR, Topham DL, Gower PE. Acute metabolic alkalosis during haemodialysis. Nephron. 1989;51(1):119\u201320.","journal-title":"Nephron."},{"issue":"3","key":"1346_CR30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0272-6386(97)90292-4","volume":"30","author":"M Kaye","year":"1997","unstructured":"Kaye M, Somerville PJ, Lowe G, Ketis M, Schneider W. Hypocalcemic tetany and metabolic alkalosis in a dialysis patient: an unusual event. Am J Kidney Dis. 1997;30(3):440\u20134.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1346_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ndt\/gfh661","volume":"20","author":"RM Heguilen","year":"2005","unstructured":"Heguilen RM, Sciurano C, Bellusci AD, Fried P, Mittelman G, Rosa Diez G, et al. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients. Nephrol Dial Transpl. 2005;20(3):591\u20137. doi: 10.1093\/ndt\/gfh661 .","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"1346_CR32","first-page":"105","volume":"59","author":"G Graziani","year":"1987","unstructured":"Graziani G, Casati S, Passerini P, Crepaldi M, Campise M, Ambroso G. Pathophysiology and clinical consequences of metabolic alkalosis in hemodialyzed patients. Arch Ital Urol Nefrol Androl. 1987;59(2):105\u201311.","journal-title":"Arch Ital Urol Nefrol Androl."},{"issue":"11","key":"1346_CR33","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/ndt\/gfg383","volume":"18","author":"L Gabutti","year":"2003","unstructured":"Gabutti L, Ferrari N, Giudici G, Mombelli G, Marone C. Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis. Nephrol Dial Transpl. 2003;18(11):2369\u201376.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"1346_CR34","doi-asserted-by":"publisher","first-page":"653","DOI":"10.5301\/jn.5000036","volume":"25","author":"B Iorio Di","year":"2012","unstructured":"Di Iorio B, Torraca S, Piscopo C, Sirico ML, Di Micco L, Pota A, et al. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects. J Nephrol. 2012;25(5):653\u201360. doi: 10.5301\/jn.5000036 .","journal-title":"J Nephrol."},{"issue":"5","key":"1346_CR35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/039139888701000502","volume":"10","author":"NG Bazilinski","year":"1987","unstructured":"Bazilinski NG, Dunea G, Ing TS. Treatment of metabolic alkalosis in renal failure. Int J Artif Organs. 1987;10(5):284\u20136.","journal-title":"Int J Artif Organs"},{"issue":"4","key":"1346_CR36","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/j.ajkd.2013.03.035","volume":"62","author":"F Tentori","year":"2013","unstructured":"Tentori F, Karaboyas A, Robinson BM, Morgenstern H, Zhang J, Sen A, et al. Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2013;62(4):738\u201346. doi: 10.1053\/j.ajkd.2013.03.035 .","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1346_CR37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ndt\/gfg472","volume":"19","author":"M Feriani","year":"2004","unstructured":"Feriani M, Passlick-Deetjen J, Jaeckle-Meyer I, La Greca G, Study G. Individualized bicarbonate concentrations in the peritoneal dialysis fluid to optimize acid-base status in CAPD patients. Nephrol Dial Transplant. 2004;19(1):195\u2013202.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1346_CR38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/089686080302300208","volume":"23","author":"K Otte","year":"2003","unstructured":"Otte K, Gonzalez MT, Bajo MA, del Peso G, Heaf J, Garcia Erauzkin G, et al. Clinical experience with a new bicarbonate (25\u00a0mmol\/L)\/lactate (10\u00a0mmol\/L) peritoneal dialysis solution. Perit Dial Int. 2003;23(2):138\u201345.","journal-title":"Perit Dial Int"},{"issue":"4","key":"1346_CR39","first-page":"238","volume":"48","author":"J Uribarri","year":"1997","unstructured":"Uribarri J. Moderate metabolic acidosis and its effects on nutritional parameters in hemodialysis patients. Clin Nephrol. 1997;48(4):238\u201340.","journal-title":"Clin Nephrol"},{"key":"1346_CR40","first-page":"242","volume":"17","author":"LS Ibels","year":"1980","unstructured":"Ibels LS. The pathogenesis of metastatic calcification in uraemia. Prog Biochem Pharmacol. 1980;17:242\u201350.","journal-title":"Prog Biochem Pharmacol"},{"issue":"6","key":"1346_CR41","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1681\/ASN.V661607","volume":"6","author":"DC Harris","year":"1995","unstructured":"Harris DC, Yuill E, Chesher DW. Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk. J Am Soc Nephrol. 1995;6(6):1607\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1346_CR42","first-page":"258","volume":"10","author":"JE Tattersall","year":"1995","unstructured":"Tattersall JE, Dick C, Doyle S, Greenwood RN, Farrington K. Alkalosis and hypomagnesaemia: unwanted effects of a low-calcium CAPD solution. Nephrol Dial Transpl. 1995;10(2):258\u201362.","journal-title":"Nephrol Dial Transpl"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1346-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1346-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1346-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T05:53:56Z","timestamp":1657518836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1346-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1346-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2016,10,25]]}}}